BLSM

BlossomHill Therapeutics, Inc.CIK 1839970 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

$50.36M

14 trades · 8 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

$50.36M

Insiders on file

AI insights for BLSM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for BLSM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Liptak Vincent Paul	General Counsel	10	$149.4K	$0	2026-08-10
Cormorant Private Healthcare Fund VI, LP	10% Owner	6	$5.00M	$0	2026-08-10
OrbiMed Capital GP VIII LLC	Director	5	$10.00M	$0	2026-08-10
Agrawal Sundeep	Director	6	$0	$0	2026-08-10
Cui Jingrong Jean	President and CEO, Director, 10% Owner	14	$0	$0	2026-08-10
Li Yishan	Executive Chairman, Director, 10% Owner	14	$0	$0	2026-08-10
Keyes Jason A	Chief Financial Officer	4	$22.4K	$0	2026-08-10
Chen Bihua	Director, 10% Owner	6	$5.00M	$0	2026-08-10
Schmid John P.	Director	2	$192.0K	$0	2026-08-10
GORDON CARL L	Director	12	$20.00M	$0	2026-08-10
ORBIMED ADVISORS LLC	Director	5	$10.00M	$0	2026-08-10
Oxnard Geoffrey Raymond	Chief Medical Officer	2	$0	$0	2026-08-06

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Cui Jingrong Jean	President and CEO	C Conversion deriv	2026-08-10	2026-08-10	124,779	—	$0	0	SEC↗
Cui Jingrong Jean	President and CEO	C Conversion deriv	2026-08-10	2026-08-10	113,435	—	$0	0	SEC↗
Cui Jingrong Jean	President and CEO	C Conversion deriv	2026-08-10	2026-08-10	1,600,682	—	$0	0	SEC↗
Li Yishan	Executive Chairman	C Conversion deriv	2026-08-10	2026-08-10	124,779	—	$0	0	SEC↗
Li Yishan	Executive Chairman	C Conversion deriv	2026-08-10	2026-08-10	1,600,682	—	$0	0	SEC↗
Li Yishan	Executive Chairman	C Conversion deriv	2026-08-10	2026-08-10	113,435	—	$0	0	SEC↗
Liptak Vincent Paul	General Counsel	C Conversion deriv	2026-08-10	2026-08-10	22,687	—	$0	0	SEC↗
Agrawal Sundeep	Director	C Conversion deriv	2026-08-10	2026-08-10	578,524	—	$0	0	SEC↗
Cormorant Private Healthcare F	10% Owner	C Conversion deriv	2026-08-10	2026-08-10	1,599,993	—	$0	0	SEC↗
Cormorant Private Healthcare F	10% Owner	C Conversion deriv	2026-08-10	2026-08-10	1,701,541	—	$0	0	SEC↗
OrbiMed Capital GP VIII LLC	Director	C Conversion deriv	2026-08-10	2026-08-12	1,049,283	—	$0	0	SEC↗
OrbiMed Capital GP VIII LLC	Director	C Conversion deriv	2026-08-10	2026-08-12	1,039,996	—	$0	0	SEC↗
GORDON CARL L	Director	C Conversion deriv	2026-08-10	2026-08-12	1,039,996	—	$0	0	SEC↗
GORDON CARL L	Director	C Conversion deriv	2026-08-10	2026-08-12	1,049,283	—	$0	0	SEC↗
Cui Jingrong Jean	President and CEO	C Conversion	2026-08-10	2026-08-10	113,435	—	$0	1,714,117	SEC↗
Cui Jingrong Jean	President and CEO	C Conversion	2026-08-10	2026-08-10	124,779	—	$0	124,779	SEC↗
Cui Jingrong Jean	President and CEO	C Conversion	2026-08-10	2026-08-10	1,600,682	—	$0	1,600,682	SEC↗
Li Yishan	Executive Chairman	C Conversion	2026-08-10	2026-08-10	1,600,682	—	$0	1,600,682	SEC↗
Li Yishan	Executive Chairman	C Conversion	2026-08-10	2026-08-10	124,779	—	$0	124,779	SEC↗
Li Yishan	Executive Chairman	C Conversion	2026-08-10	2026-08-10	113,435	—	$0	1,714,117	SEC↗
Liptak Vincent Paul	General Counsel	C Conversion	2026-08-10	2026-08-10	22,687	—	$0	22,687	SEC↗
Liptak Vincent Paul	General Counsel	P Buy	2026-08-10	2026-08-10	2,200	$16.00	$35.2K	111,412	SEC↗
Keyes Jason A	Chief Financial Officer	P Buy	2026-08-10	2026-08-10	700	$16.00	$11.2K	700	SEC↗
Agrawal Sundeep	Director	C Conversion	2026-08-10	2026-08-10	578,524	—	$0	578,524	SEC↗
Cormorant Private Healthcare F	10% Owner	C Conversion	2026-08-10	2026-08-10	1,701,541	—	$0	3,301,534	SEC↗
Cormorant Private Healthcare F	10% Owner	C Conversion	2026-08-10	2026-08-10	1,599,993	—	$0	1,599,993	SEC↗
Cormorant Private Healthcare F	10% Owner	P Buy	2026-08-10	2026-08-10	312,500	$16.00	$5.00M	3,614,034	SEC↗
Schmid John P.	Director	P Buy	2026-08-10	2026-08-10	6,000	$16.00	$96.0K	6,000	SEC↗
OrbiMed Capital GP VIII LLC	Director	P Buy	2026-08-10	2026-08-12	625,000	$16.00	$10.00M	2,714,279	SEC↗
OrbiMed Capital GP VIII LLC	Director	C Conversion	2026-08-10	2026-08-12	1,049,283	—	$0	2,089,279	SEC↗
OrbiMed Capital GP VIII LLC	Director	C Conversion	2026-08-10	2026-08-12	1,039,996	—	$0	1,039,996	SEC↗
GORDON CARL L	Director	P Buy	2026-08-10	2026-08-12	625,000	$16.00	$10.00M	2,714,279	SEC↗
GORDON CARL L	Director	C Conversion	2026-08-10	2026-08-12	1,039,996	—	$0	1,039,996	SEC↗
GORDON CARL L	Director	C Conversion	2026-08-10	2026-08-12	1,049,283	—	$0	2,089,279	SEC↗
Liptak Vincent Paul	General Counsel	C Conversion deriv	2026-08-10	2026-08-10	22,687	—	—	0	SEC↗
Liptak Vincent Paul	General Counsel	C Conversion	2026-08-10	2026-08-10	22,687	—	—	22,687	SEC↗
Liptak Vincent Paul	General Counsel	P Buy	2026-08-10	2026-08-10	2,200	$16.00	$35.2K	111,412	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion deriv	2026-08-10	2026-08-10	124,779	—	—	0	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion deriv	2026-08-10	2026-08-10	113,435	—	—	0	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion deriv	2026-08-10	2026-08-10	1,600,682	—	—	0	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion	2026-08-10	2026-08-10	124,779	—	—	124,779	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion	2026-08-10	2026-08-10	113,435	—	—	1,714,117	SEC↗
Cui Jingrong Jean	President and CEO, Director,	C Conversion	2026-08-10	2026-08-10	1,600,682	—	—	1,600,682	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion deriv	2026-08-10	2026-08-10	124,779	—	—	0	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion deriv	2026-08-10	2026-08-10	113,435	—	—	0	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion deriv	2026-08-10	2026-08-10	1,600,682	—	—	0	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion	2026-08-10	2026-08-10	124,779	—	—	124,779	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion	2026-08-10	2026-08-10	113,435	—	—	1,714,117	SEC↗
Li Yishan	Executive Chairman, Director	C Conversion	2026-08-10	2026-08-10	1,600,682	—	—	1,600,682	SEC↗
Keyes Jason A	Chief Financial Officer	P Buy	2026-08-10	2026-08-10	700	$16.00	$11.2K	700	SEC↗
Schmid John P.	Director	P Buy	2026-08-10	2026-08-10	6,000	$16.00	$96.0K	6,000	SEC↗
Chen Bihua	Director, 10% Owner	C Conversion deriv	2026-08-10	2026-08-10	1,701,541	—	—	0	SEC↗
Chen Bihua	Director, 10% Owner	C Conversion deriv	2026-08-10	2026-08-10	1,599,993	—	—	0	SEC↗
Chen Bihua	Director, 10% Owner	P Buy	2026-08-10	2026-08-10	312,500	$16.00	$5.00M	3,614,034	SEC↗
Chen Bihua	Director, 10% Owner	C Conversion	2026-08-10	2026-08-10	1,701,541	—	—	3,301,534	SEC↗
Chen Bihua	Director, 10% Owner	C Conversion	2026-08-10	2026-08-10	1,599,993	—	—	1,599,993	SEC↗
Agrawal Sundeep	Director	C Conversion deriv	2026-08-10	2026-08-10	578,524	—	—	0	SEC↗
Agrawal Sundeep	Director	C Conversion	2026-08-10	2026-08-10	578,524	—	—	578,524	SEC↗
GORDON CARL L	Director	C Conversion deriv	2026-08-10	2026-08-12	1,049,283	—	$0	0	SEC↗
GORDON CARL L	Director	C Conversion deriv	2026-08-10	2026-08-12	1,039,996	—	$0	0	SEC↗
GORDON CARL L	Director	P Buy	2026-08-10	2026-08-12	625,000	$16.00	$10.00M	2,714,279	SEC↗
GORDON CARL L	Director	C Conversion	2026-08-10	2026-08-12	1,049,283	—	—	2,089,279	SEC↗
GORDON CARL L	Director	C Conversion	2026-08-10	2026-08-12	1,039,996	—	—	1,039,996	SEC↗
ORBIMED ADVISORS LLC	Director	C Conversion deriv	2026-08-10	2026-08-12	1,049,283	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director	C Conversion deriv	2026-08-10	2026-08-12	1,039,996	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director	P Buy	2026-08-10	2026-08-12	625,000	$16.00	$10.00M	2,714,279	SEC↗
ORBIMED ADVISORS LLC	Director	C Conversion	2026-08-10	2026-08-12	1,049,283	—	—	2,089,279	SEC↗
ORBIMED ADVISORS LLC	Director	C Conversion	2026-08-10	2026-08-12	1,039,996	—	—	1,039,996	SEC↗
Liptak Vincent Paul	General Counsel	P Buy	2026-08-07	2026-08-10	2,500	$15.80	$39.5K	109,212	SEC↗
Liptak Vincent Paul	General Counsel	P Buy	2026-08-07	2026-08-10	2,500	$15.80	$39.5K	109,212	SEC↗
Cui Jingrong Jean	President and CEO	A Award deriv	2026-08-06	2026-08-10	676,205	—	$0	676,205	SEC↗
Li Yishan	Executive Chairman	A Award deriv	2026-08-06	2026-08-10	112,701	—	$0	112,701	SEC↗
Oxnard Geoffrey Raymond	Chief Medical Officer	A Award deriv	2026-08-06	2026-08-10	61,783	—	$0	61,783	SEC↗
Liptak Vincent Paul	General Counsel	A Award deriv	2026-08-06	2026-08-10	46,561	—	$0	46,561	SEC↗
Keyes Jason A	Chief Financial Officer	A Award deriv	2026-08-06	2026-08-10	56,746	—	$0	56,746	SEC↗
Agrawal Sundeep	Director	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗
Cormorant Private Healthcare F	10% Owner	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗
GORDON CARL L	Director	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗
Oxnard Geoffrey Raymond	Chief Medical Officer	A Award deriv	2026-08-06	2026-08-10	61,783	—	$0	61,783	SEC↗
Liptak Vincent Paul	General Counsel	A Award deriv	2026-08-06	2026-08-10	46,561	—	$0	46,561	SEC↗
Cui Jingrong Jean	President and CEO, Director,	A Award deriv	2026-08-06	2026-08-10	676,205	—	$0	676,205	SEC↗
Li Yishan	Executive Chairman, Director	A Award deriv	2026-08-06	2026-08-10	112,701	—	$0	112,701	SEC↗
Keyes Jason A	Chief Financial Officer	A Award deriv	2026-08-06	2026-08-10	56,746	—	$0	56,746	SEC↗
GORDON CARL L	Director	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗
Chen Bihua	Director, 10% Owner	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗
Agrawal Sundeep	Director	A Award deriv	2026-08-06	2026-08-10	23,904	—	$0	23,904	SEC↗